FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare…
Finance, IT & News
Finance, IT & News
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare…
Fitch Assigns Gorilla Technology First-Time 'B-' Rating with Positive Outlook TMX Newsfile
France Dodges Rating Rebuke as Fitch Sticks With Stable Outlook Bloomberg.com
S&P upgrades Constellation Software outlook on deleveraging Investing.com
S&P affirms Jordan ’BB-/B’ ratings on economic resilience Investing.com